Home
Conditions
Vomiting

Clinical trial condition

Vomiting

Explore clinical trials studying Vomiting. Study availability and eligibility vary by location and protocol.

542 public trials 47 recruiting studies

Refine in advanced search Browse all conditions

Vomiting trial results

Completed

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

NCT00381862

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +17 more
Locations: St. Josephs/Cander Hospital Savannah, Georgia, United States

Kaiser Permanente Hilo, Hawaii, United States

Ingalls Memorial Hospital Harvey, Illinois, United States

Kansas City Cancer Center Kansas City, Missouri, United States

View Trial Details

Completed

Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED)

NCT00337727

Conditions: Chemotherapy-induced Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
Locations: Not specified

View Trial Details

Completed

Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)

NCT00952341

Conditions: Chemotherapy-Induced Nausea and Vomiting (CINV), Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
Locations: Not specified

View Trial Details

Completed

Auricular Acupressure for Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer Patients

NCT02403037

Conditions: Breast Diseases, Breast Neoplasms, Nausea, +8 more
Locations: The Second People's Hospital of Fujian Province Fuzhou, Fujian, China

The First People's Hospital of Fujian Province Fuzhou, Fujian, China

Fujian Provincial Cancer Hospital Fuzhou, Fujian, China

View Trial Details

Completed

CV Events in Emetogenic Chemotherapy

NCT01366599

Conditions: Arterial Thromboembolic Event, Cardiovascular Event, Pathological Conditions, Signs and Symptoms, +3 more
Locations: Not specified

View Trial Details

Completed

Study of the Effect of Intramuscular Ephedrine on the Incidence of Nausea and Vomiting During Elective Cesarean Section

NCT00432991

Conditions: Cesarean Section, Nausea, Pathological Conditions, Signs and Symptoms, +3 more
Locations: New York-Presbyterian Hospital; Weill Medical College of Cornell New York, United States

View Trial Details

Completed

Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

NCT00684463

Conditions: Nausea, Neoplasms, Pathological Conditions, Signs and Symptoms, +3 more
Locations: Not specified

View Trial Details

Completed

Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)

NCT00687011

Conditions: Nausea, Neoplasms, Pathological Conditions, Signs and Symptoms, +3 more
Locations: Not specified

View Trial Details

Completed

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

NCT00248547

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +100 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Pediatric Integrative Medicine Trial Pilot

NCT02028832

Conditions: Anxiety, Anxiety Disorders, Mental Disorders, +8 more
Locations: Stollery Childrens' Hospital Edmonton, Alberta, Canada

View Trial Details

Vomiting

Vomiting trial results

Related conditions